In the wake of a Federal Trade Commission investigation into hospital group Renown Health, following a law firm’s own review of the group’s buyout of a cardiology practice, the Nevada-based business’s CEO and three other executives have resigned. Renown CEO Jim Miller has stepped down from his position after agreeing with the FTC to release 10 cardiologists from the practice the company acquired from non-compete agreements. The group additionally paid $4.2 million to a dozen cardiologists. Renown has acknowledged the antitrust probe as the reason for the CEO’s resignation; a press release from the group’s board chairman noted that “things did not go as planned” concerning the acquisition. He added, “If the execution of the SNCA transaction had been as solid as our intentions, none of this would have occurred.” SCNA, or Sierra Nevada Cardiology Associates, was acquired by Renown in March 2011.
Featured News
Trump’s Defamation Case Against New York Times Advances in Federal Court
Nov 19, 2026 by
CPI
Musk’s xAI Faces Skeptical US Judges Over California AI Disclosure Law
Nov 19, 2026 by
CPI
Italy Ends Vorwerk Antitrust Probe After Consumer Compensation Deal
Nov 19, 2026 by
CPI
Canada Wins Court Order to Advance Gap, Old Navy Advertising Probe
Nov 19, 2026 by
CPI
Russia Orders Major Retailers to Disclose Food Pricing Data in Antitrust Review
Nov 19, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Labor Market Collusion
Nov 19, 2026 by
CPI
From Price-Fixing to Wage-Fixing: Are Labor Markets the Next Frontier of Public and Private Competition Law Enforcement?
Nov 19, 2026 by
Giulia Rurali & Carsten Krüger
Damage Estimation and Labor Market Collusion
Nov 19, 2026 by
Louis D. Pape
Recent Developments of Labor Market Collusion in the EU: The Dialogue Between Delivery Hero and Tondela
Nov 19, 2026 by
Catarina Vieira Peres & Rita Ferreira Gomes
Enforcement in Labor Collusion and Monopsony: Trends and Challenges
Nov 19, 2026 by
Leyla Karakas & Anna Meyendorff